MHRA Drug Safety Update

MHRA Drug Safety Update

January 9, 2018

Date issued: 9th January 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 6, January 2018) has been published and includes articles on:

  • daclizumab (Zinbryta▼) and risk of severe liver injury: new restrictions to use and strengthened liver monitoring;
  • drug-name confusion: reminder to be vigilant for potential errors;
  • co-dydramol: prescribe and dispense by strength to minimise risk of medication error; and
  • herbal medicines: report suspected adverse reactions via the Yellow Card Scheme.

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

Menadiol 10mg tablets supply issue

PSNC has become aware that Alliance Pharmaceuticals Ltd has transferred the production of its licensed Menadiol Diphosphate Tablets 10mg to...

Health & Care Review

Plans to cut excess calorie consumption unveiled Public Health England (PHE) has announced new measures to help reduce people’s excessive...